Back to Superinvestors
SUPERINVESTOR HOLDERS

SYRE

Spyre Therapeutics Inc.
Healthcare · Biotechnology
Holders
1
Total value
$2,036,347
Total shares
22,937
Cross-link
Financials →
Investor Shares Value % of Portfolio Activity As of
Cliff Asness
AQR Capital Management
22,937 $2,036,347 0.00% ADD +2,063 30 Jun 2026